Wolters Kluwer N.V.: Share Buyback Transaction Details October 5 - 11, 2017
Oct 12, 2017 08:02 am UTC| Business
Share Buyback Transaction Details October 5 - 11, 2017 October 12, 2017 - Wolters Kluwer today reports that it has repurchased 189,918 of its own ordinary shares in the period from October 5, 2017 up to and including...
Smart Lighting Market to Reach $27,064 million by 2023: P&S Market Research
Oct 12, 2017 07:30 am UTC| Business
NEW YORK, Oct. 12, 2017 -- According to new market research report titled “Smart Lighting Market by Source (Light Emitting Diode, Fluorescent Lamp, High Intensity Discharge Lamp), by Product (Luminaries, Lighting...
Oct 12, 2017 07:00 am UTC| Business
− ONO Rights Include Oncology Indications for Selinexor and KPT-8602 in Japan, South Korea, Taiwan, Hong Kong and ASEAN countries – − Karyopharm to Receive ¥2.5 billion (US$22.3 Million) Upfront; Total Deal Value up to...
Process Analytical Technology Market to Reach $4 billion by 2023: P&S Market Research
Oct 12, 2017 06:30 am UTC| Business
NEW YORK, Oct. 12, 2017 -- According to the new market research report titled “Process Analytical Technology (PAT) Market by Technique (Spectroscopy, Chromatography, Capillary Electrophoresis, Particle Size Analysis),...
ACI Worldwide and STET Team to Drive European Immediate Payments Adoption
Oct 12, 2017 06:00 am UTC| Business
NAPLES, FLA and Paris, France, Oct. 12, 2017 -- ACI Worldwide (NASDAQ: ACIW), a leading global provider of real-time electronic payment and banking solutions, and STET, one of the leading European clearing and...
DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut
Oct 12, 2017 05:32 am UTC| Business
Press Release Montrouge, France, October 12, 2017 DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut 97.5% of patients continue treatment in the open-label arm of the...
Sanofi invests €170 million in new vaccine production facility in France
Oct 12, 2017 05:03 am UTC| Business
Sanofi invests €170 million in new vaccine production facility in France - Expansion at Val de Reuil reinforces the company's position as a global leader in seasonal flu vaccines - Paris, France - October 12,...